Bio Path reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
Baxter International USD 8.62B 852M Mar/2026
Bio Path USD 0 0 Mar/2025
Cipla INR 3.82B 840.2M Mar/2026
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Grifols EUR 9.95B 722.93M Dec/2025
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025